Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Rosset

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Biomaterials|March 31, 2018
Feasibility and safety of treating non-unions in tibia, femur and humerus with autologous, expanded, bone marrow-derived mesenchymal stromal cells associated with biphasic calcium phosphate biomaterials in a multicentric, non-comparative trialEnrique Gómez-Barrena, Philippe Rosset, Florian Gebhard, et al.
Injury|March 7, 2020
Early efficacy evaluation of mesenchymal stromal cells (MSC) combined to biomaterials to treat long bone non-unionsEnrique Gómez-Barrena, Norma Padilla-Eguiluz, Philippe Rosset, et al.
International Journal of Cancer|March 30, 2019
Sarcomas in patients over 90: Natural history and treatment-A nationwide study over 6 yearsClémence Basse, Antoine Italiano, Nicolas Penel, et al.
Stem Cells International|March 15, 2018
A Multicentric, Open-Label, Randomized, Comparative Clinical Trial of Two Different Doses of Expanded hBM-MSCs Plus Biomaterial versus Iliac Crest Autograft, for Bone Healing in Nonunions after Long Bone Fractures: Study ProtocolEnrique Gómez-Barrena, Norma G Padilla-Eguiluz, Cristina Avendaño-Solá, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Biomaterials|March 31, 2018
Feasibility and safety of treating non-unions in tibia, femur and humerus with autologous, expanded, bone marrow-derived mesenchymal stromal cells associated with biphasic calcium phosphate biomaterials in a multicentric, non-comparative trialEnrique Gómez-Barrena, Philippe Rosset, Florian Gebhard, et al.
Injury|March 7, 2020
Early efficacy evaluation of mesenchymal stromal cells (MSC) combined to biomaterials to treat long bone non-unionsEnrique Gómez-Barrena, Norma Padilla-Eguiluz, Philippe Rosset, et al.
International Journal of Cancer|March 30, 2019
Sarcomas in patients over 90: Natural history and treatment-A nationwide study over 6 yearsClémence Basse, Antoine Italiano, Nicolas Penel, et al.
Stem Cells International|March 15, 2018
A Multicentric, Open-Label, Randomized, Comparative Clinical Trial of Two Different Doses of Expanded hBM-MSCs Plus Biomaterial versus Iliac Crest Autograft, for Bone Healing in Nonunions after Long Bone Fractures: Study ProtocolEnrique Gómez-Barrena, Norma G Padilla-Eguiluz, Cristina Avendaño-Solá, et al.
Pageof 8